SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $645,000 | -45.0% | 8,656 | +25.8% | 0.02% | -54.1% |
Q4 2020 | $1,173,000 | +40.3% | 6,882 | +15.6% | 0.04% | +5.7% |
Q3 2020 | $836,000 | -3.9% | 5,951 | +9.7% | 0.04% | -22.2% |
Q2 2020 | $870,000 | +20.7% | 5,425 | -25.9% | 0.04% | +40.6% |
Q1 2020 | $721,000 | -22.1% | 7,319 | +2.1% | 0.03% | -3.0% |
Q4 2019 | $925,000 | +62.0% | 7,168 | -5.5% | 0.03% | +57.1% |
Q3 2019 | $571,000 | – | 7,582 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |